Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Q Lacy

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Blood Cancer Journal|March 21, 2015
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myelomaW I Gonsalves, N Leung, S V Rajkumar, et al.
Leukemia|February 20, 2003
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaC S Debes-Marun, G W Dewald, S Bryant, et al.
Heart (British Cardiac Society)|January 10, 2014
High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosisA Dispenzieri, M A Gertz, S K Kumar, et al.
Leukemia|March 3, 2006
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocationsW J Chng, R Santana-Dávila, S A Van Wier, et al.
Leukemia|May 24, 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survivalE Muchtar, A Dispenzieri, S K Kumar, et al.
Leukemia|January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapyA K Stewart, P L Bergsagel, P R Greipp, et al.
Blood Cancer Journal|May 2, 2015
Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for deathR Warsame, S K Kumar, M A Gertz, et al.
Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.
Blood Cancer Journal|May 30, 2023
Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic ExperienceI Vaxman, S K Kumar, F Buadi, et al.
Leukemia|January 25, 2008
Genetic aberrations and survival in plasma cell leukemiaR E Tiedemann, N Gonzalez-Paz, R A Kyle, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Blood Cancer Journal|March 21, 2015
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myelomaW I Gonsalves, N Leung, S V Rajkumar, et al.
Leukemia|February 20, 2003
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaC S Debes-Marun, G W Dewald, S Bryant, et al.
Heart (British Cardiac Society)|January 10, 2014
High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosisA Dispenzieri, M A Gertz, S K Kumar, et al.
Leukemia|March 3, 2006
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocationsW J Chng, R Santana-Dávila, S A Van Wier, et al.
Leukemia|May 24, 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survivalE Muchtar, A Dispenzieri, S K Kumar, et al.
Leukemia|January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapyA K Stewart, P L Bergsagel, P R Greipp, et al.
Blood Cancer Journal|May 2, 2015
Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for deathR Warsame, S K Kumar, M A Gertz, et al.
Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.
Blood Cancer Journal|May 30, 2023
Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic ExperienceI Vaxman, S K Kumar, F Buadi, et al.
Leukemia|January 25, 2008
Genetic aberrations and survival in plasma cell leukemiaR E Tiedemann, N Gonzalez-Paz, R A Kyle, et al.
Pageof 15